Business Wire

Seoul Semiconductor's LED SunLike Improves Eye Health and Sleep Quality, According to Clinical Study

Jaa

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global market leader in LED (light emitting diode) design and manufacturing, announced that a research has shown that its “SunLike” is an optimized LED for human centric lighting that improves eye health and sleep quality.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180712005307/en/

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric light ...

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric lighting (Graphic: Business Wire)

The research team of Biomedical Information Laboratory, Seoul National University College of Medicine in Korea, has reported that using SunLike based lighting, the eye discomfort is significantly reduced and the sleep quality is improved compared to conventional LED lighting users.

The researchers conducted experiments on adults including graduate students at Seoul National University, who spend a lot of time studying at their desk indoors. Each participant was instructed to use SunLike desk lamp and conventional LED lamp for 3 hours before bedtime. The team conducted a questionnaire and analyzed the vital signs of participants recorded during sleep.

Subjective evaluation through questionnaires showed a significant decrease in eye fatigue and a marked improvement in sleep quality. The researchers found that improvement of the feeling of not refreshing after a sleep in the following morning was statistically significant.

As a result of analyzing the measured vital sign, the time it takes to fall asleep is 23% faster and the time to break during sleep was also improved by 43%. Therefore, the research team found that sleep efficiency as an indicator of sleep was significantly improved from 88% to 94%.

“We conclude that these effects are due to the stabilization of the autonomic nervous system rhythm, which is manifested by inactivation of sympathetic nerve and activity of parasympathetic nerve by SunLike based lighting,” said the research team of SNU. “Light affects people’s circadian rhythm. In order to improve biorhythm, we can adjust the light according to time zone and use a light source close to sunlight,” said the research team of SNU.

SunLike is an advanced light source that combines the latest optical and compound semiconductor technology of Seoul Semiconductor and *TRI-R technology, a sunlight spectrum reproduction technology, that is a registered trademark by the Toshiba Materials Co., Ltd. It that lowers blue light peak similar to sunlight spectrum contributes to maintaining a stable human circadian rhythms and enhancing the color clarity of objects.

In addition, as a result of analyzing the blue light emitted by the LED ‘SunLike’, it received Eye Safety Certification for level RG-1, the highest level of safety, from Korea Testing & Research Institute last November. This is the level given to a safe light source without any photobiological hazards.

“Since its launch on June 29th, last year in Frankfurt, Germany, with Toshiba Materials Co., Ltd., SunLike has being supplied to global customers in US, Europe, China and Japan that manufacture home lightings, smart desk stands and lamps. It is also currently working on more than 200 projects for SunLike with customers, suppliers and researchers,” said Minsoo Son, marketing vice president of Seoul Semiconductor. “We will prove SunLike is the innovative LED which adds value for human centric lighting by demonstrating differentiated quality and competitiveness to exceed customers’ expectations.”

*TRI-R, supported by Toshiba Materials, finds in the definition “The light closest to the sun for human well-being” as its original concept. The sun light spectrum is developed by the same company and can be reproduced by a white LED light source technology.

About Seoul Semiconductor
Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC. To learn more, visit www.seoulsemicon.com.

Contact information

Seoul Semiconductor Co., Ltd.
Korea and Asia
Jeonghee Kim
+82-70-4391-8311
+82-10-4843-6303
jeonghee.kim@seoulsemicon.com
Americas
Andrew Smith
+1 (901) 831-6614
andrew.smith@seoulsemicon.com
China
Vincent Wu
+86-1391-7898226
vincent.wu@seoulsemicon.com
Europe
Marc Juarez
+49 89 450 36 90 31
marc.juarez@seoulsemicon.com
Japan
Kohei Shimooka
+81-80-4668-9710
kohei.shimooka@seoulsemicon.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 22:41Tiedote

Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 20:21Tiedote

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 19:00Tiedote

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 15:38Tiedote

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 15:05Tiedote

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 15:00Tiedote

Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme